97 Small Cap Stocks Hit 52-Week Highs On Tuesday

SPY: State Street SPDR S&P 500 ETF Trust logo
SPY
State Street SPDR S&P 500 ETF Trust

A new list of market leaders is heavily concentrated in one particular industry, raising questions about the breadth of today’s strength.

Halozyme Therapeutics (HALO) is the largest company on today’s list, with a market value of about $9.9 billion. It leads a group of 97 Small Cap stocks from the Russell 3000 trading at their 52-week highs.

The list is dominated by a single industry, with 21 names from Regional Banks. This raises a central question: is this a broad show of strength, or a narrow one? The names below show the day’s full range.

Photo by ArtsyBee on Pixabay

The 10 Largest, By Market Cap

Relevant Articles
  1. UPS: A Cash Gusher At A Marked-Down Price
  2. The Real Price of AbbVie Stock Is Cheaper Than You Think
  3. ORCL Is Back At A Level It Has Defended Before
  4. Decoding PLTR Stock’s Premium Valuation
  5. Get Paid 13% To Cap Your BKNG Stock At 15% Higher
  6. Why SIRI Stock Hands You So Much Cash Right Now

The table below shows the 10 largest of the 97 names, sorted by market capitalization, with returns over four windows:

Tickers Market
Cap
1D
% Chg
1W
% Chg
1M
% Chg
1Y
% Chg
HALO $9.9 Bil 2.4% 6.2% 11.3% 43.3%
ADC $9.7 Bil 0.8% 1.1% 5.7% 15.1%
CUBE $9.7 Bil 0.5% 3.9% 4.4% 8.5%
BRKR $9.6 Bil 4.8% 4.1% 3.3% 50.7%
AXS $8.8 Bil 1.9% 4.1% 10.1% 25.1%
CBSH $8.7 Bil 1.7% 2.8% 3.8% 3.6%
RHP $8.6 Bil 0.8% 4.6% 3.9% 43.1%
EAT $8.6 Bil 1.4% 2.8% 15.6% 29.1%
LAD $8.4 Bil 3.7% 8.3% 22.7% 15.4%
ETSY $8.3 Bil 3.1% 5.9% 10.8% 38.4%

Which names have the business growth to earn their new price?

Halozyme (HALO) stands out with revenue growth of 39.1% over the last twelve months and an operating margin of 56.1%. The stock trades at 28.3 times trailing earnings. For comparison, Agree Realty (ADC), the second-largest name, trades at 44.3 times trailing earnings while its revenue grew 17.8%.

So is a new high simply a signal to buy?

A 52-week high means a stock is at its strongest price of the last year, and that strength can persist. But a price is not a verdict on the business itself. The disciplined move is to treat this list as a starting point for research, not a finish line. The essential work is to check whether the company’s fundamentals can support its new valuation.

A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.

Chasing Highs Is A Reflex. Owning Strength Is A System

A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.

The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.